Evidence map›Paper›PMID 41655156›Full record

ArticleEJNMMI physics2026

Analysis of external dose rate attenuation and its related factors in differentiated thyroid carcinoma patients following I-131 therapy.

Zimeng Sun, Fengyi Huang, Youjia Zhang, Yue Jin, Shuman Yang, Shi Gao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zimeng SunDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, 130021, Jilin, China.
Fengyi HuangDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, 130021, Jilin, China.
Youjia ZhangDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Yue JinDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.
Shuman YangDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, 130021, Jilin, China. shumanyang@jlu.edu.cn.ORCID http://orcid.org/0000-0002-9169-5850
Shi GaoDepartment of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China. gaoshi@jlu.edu.cn.

Funding

Jilin Provincial Scientific and Technological Development Program 20250206008ZP
6 · The paper itself

Abstract

backgroundMonitoring the external dose rate (EDR) attenuation serves as a key consideration in supporting discharge decisions for patients with differentiated thyroid cancer (DTC) who have undergone radioiodine therapy. We aimed to study the EDR attenuation and its related factors in DTC patients during I-131 therapy.

methodsThis study enrolled 886 DTC patients who first underwent I-131 therapy at the Third Bethune Hospital of Jilin University, China. We measured the EDR at approximately 2, 24, 48, and 72 h post-therapy. Two formulas were established to represent the EDR decay with time: 1) EDR =[Formula: see text] and EDR

resultsThe finally fitted SI and SI

conclusionsEDR

Indexed as

Differentiated thyroid cancerExternal dose rateI-131 therapyRadioactive safety assessmentRisk factors

Identifiers

PMID41655156
PMCPMC12988089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.